Quantum eMotion Achieves Major Milestone with NYSE American Listing

Quantum eMotion Corp. begins trading on NYSE American (QNC) today, testing its 105% 90-day rally. The uplist follows a premium valuation and key tech milestones.

In a significant capital markets move, Quantum eMotion Corp. is set to commence trading on the NYSE American exchange today. This uplisting marks the company's departure from the OTCQB Venture Market, representing its most substantial step to date in attracting investor attention. The transition will serve as a key test for the stock's recent momentum, determining whether its performance can be sustained on a prominent U.S. trading platform.

A New Trading Venue and Symbol

The company confirmed last Thursday that its common shares had received approval for listing on the NYSE American. Trading under the ticker symbol QNC is scheduled to begin at or around the market open today. Concurrently, the stock’s quotation on the OTCQB will be terminated. Shareholders do not need to take any action, though the firm advises investors who purchased shares on the OTCQB to verify that their holdings have been correctly transferred to the new listing.

Quantum eMotion's equity will continue to be traded on the TSX Venture Exchange (also under QNC) and the Frankfurt Stock Exchange (under 34Q0).

Lofty Valuation Amidst a Powerful Rally

This listing follows a period of exceptional share price strength. According to data from Simply Wall St., the stock's performance prior to the uplisting showed a +10.75% single-day gain, a +42.72% increase over seven days, and a remarkable +105.41% surge across 90 days. In this analysis, the share price was noted at approximately 6.08 CAD.

This rally has propelled the company's valuation to a premium level. Simply Wall St. calculates a price-to-book ratio of 52.1, which stands in stark contrast to the Canadian semiconductor industry average of 2.2. Furthermore, the company currently reports no revenue. Its most recent quarterly filing, for the nine-month period ending September 30, 2025, disclosed a net loss of 6.56 million CAD (S&P Capital IQ/MarketScreener).

Drivers of Investor Enthusiasm

The regulatory path to the NYSE American was paved by the filing of a Form 40-F registration statement in late January. Management and reporting cite enhanced visibility among institutional investors and improved liquidity as primary reasons for the uplisting. The company simultaneously emphasizes its ongoing shift from research and development toward the commercialization of its "Entropy-as-a-Service" platform.

Several recent developments provide context for the heightened market interest:

• Progress toward FIPS 140-3 validation for a quantum cryptography module, in collaboration with Lightship Security.
• A DeFi security audit of its QRNG2 technology that resulted in a perfect score of 100/100 with "zero findings," as per a prior company release.
• Inclusion as a top holding in the Defiance Quantum ETF in December.
• A healthcare sector partnership announced in December, focusing on remote patient monitoring and chronic care in U.S. senior living facilities.

Adding to today's events, CEO Francis Bellido is scheduled to present at an InvestorTalk session this morning (U.S. Eastern Time).

The structural shift to the NYSE American broadens market access, replacing the OTCQB quote while maintaining the Canadian and Frankfurt listings. Ultimately, the sustainability of its substantial valuation premium will hinge on the company's ability to convert its technology pipeline into tangible revenue in the foreseeable future.